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Abstract. The use of carbon nanotubes as a gene delivery system has been extensively 
studied in recent years owing to its potential advantages over viral vectors. To achieve this 
goal, carbon nanotubes have to be functionalized to become compatible with aqueous media 
and to bind the genetic material. To establish the best conditions for plasmid DNA binding, 
we compare the dispersion properties of single-, double- and multi-walled carbon nanotubes 
(SWCNTs, DWCNTs and MWCNTs respectively) functionalized with a variety of surfactants 
by non-covalent attachment. The DNA binding properties of the functionalized carbon 
nanotubes were studied and compared by electrophoresis. Furthermore, a bilayer 
functionalization method for DNA binding on SWCNTs was developed that utilized RNA-
wrapping to solubilise the nanotubes and cationic polymers as a bridge between nanotubes 
and DNA.  
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1. Introduction 
In recent years increased attention has been paid to nano-structured materials such as carbon 
nanotubes. Carbon nanotubes have received considerable interest in the biomedical field in 
areas such as drug and gene delivery, scaffolds for tissue growth, biosensing and diagnostics, 
because of their biocompatibility, low cytotoxicity and their ability to cross the cell 
membrane[1 - 4]. Although the exact mechanisms by which CNTs cross the cell membrane 
are under debate[5,6] much research has shown that CNTs accumulate in the cell without 
toxic effects[3,4]. Encouraging, SWCNT localise in tumours in mice, probably because of 
increased vascularisation inherent in tumours, making tumour targeting a feasible 
approach[7]. However, one of the still remaining problems when using carbon nanotubes for 
these applications is the inherent difficulty in handling them as they tend to aggregate in 
bundles through strong attractive interactions which are very difficult to disrupt. Therefore, 
the development of functionalization methods to obtain stable suspensions of carbon 
nanotubes is primordial. Functionalization of CNTs has been performed by covalent and non-
covalent approaches[8]. Covalent modification (i.e. amidation[9], esterification[10], reduction 
of nitro groups[11] and cleavable disulfides[12]) changes the structural and electrical 
properties of CNTs whereas non-covalent approaches retain CNTs in their native state. 
Furthermore, non-covalent methods are usually quite simple and quick, involving steps such 
as ultrasonication, centrifugation and filtration. Besides, when using carbon nanotubes for 
biomedical applications, the functionalization method has crutial implications. For example, 
the retention of the native structure of the carbon nanotube can be advantageous for CNT 
taking-up and processing in the cell. However, the surfactant has to be carefully selected as 
they are known to permeabilize plasma membranes being cytotoxic on their own which could 
limit the possible biomedical applications of such functionalized carbon nanotubes.  
 One of the most promising research applications in the field of nanotechnology has been the 
use of carbon nanotubes (CNTs) as gene delivery systems for silencing deleterious 
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genes[12,13]. However, the use of carbon nanotubes as gene delivery vectors requires 
functionalization to disperse the nanotubes in aqueous media and to render them able to 
effectively bind to DNA. It has been reported that a variety of single-stranded DNAs, short 
double-stranded DNAs, and RNAs can disperse SWCNTs [14, 15], and that DNA is able to 
insert into the opened cavity of MWCNTs in a non-specific manner[16]. However, these 
methodologies would require high amounts of the purified genetic material in order to 
functionalize and use them as gene delivery systems. Different covalent methodologies have 
been developed based on the chemical modification of the carbon nanotube surface to 
introduce positively charged groups or maleimide groups for DNA binding through ionic 
interactions or through covalent bounds to thiol-terminated oligonucleotides, respectively. 
However, as it was stated above, these methods disrupt the structure of carbon nanotubes and 
also the functionalization procedures are usually time consuming and tedious. The use of non-
covalent approaches is an alternative to these methods. The use of non-covalent approaches 
renders the cationic groups available for negatively charged DNA binding by ionic 
interactions. However, there has been no systematic investigation of the functionalization of 
CNTs for optimal binding of DNA, which is the subject of this study. In this paper, a 
comparative study on the non-covalent functionalization of CNTs for DNA binding is 
presented. The general approach was to use amphiphilic molecules that wrap the surface of 
CNTs through their hydrophobic regions leaving the hydrophilic groups exposed rendering 
them soluble in aqueous media. Tests were carried out with single-walled, double-walled and 
multi-walled carbon nanotubes (SWCNTs, DWCNTs, MWCNTs, respectively) in order to 
compare their dispersion properties. Cationic surfactants that can effectively bind negatively 
charged DNA were additionally used to bind plasmid DNA for designing functionalized 
CNTs for gene delivery purposes. Furthermore, the introduction of the cationic 
functionalities, mainly amine groups, allows further attachment of groups such as targeting 
moieties for targeting purposes and fluorophore markers for cell tracking. In addition, a new 
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functionalization method for DNA binding based on a bilayer approach with RNA-wrapped 
SWCNTs is also presented. The functionalization methods and conclusions described in this 
work for DNA binding to carbon nanotubes are not only important for gene delivery purposes 
but also for other applications of carbon nanotubes in the biomedical field such as biosensing.  
2. Materials and methods  
2.1. Materials.  
Carbon nanotubes were prepared by the CVD method in our lab[17 - 19]. Benzalkonium 
chloride from Fluka 12060 > 95.0 %; polyethyleneimine (PEI) from Sigma P3143 50 % w/v; 
1-pyrenemethylamide hydrochloride (PMA) 95 % from Aldrich 401633; 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)2000 (PL-PEG-NH2) from 
Avanti Polar Lipids 880128P; 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (Lyso-PC) 
form Avanti Polar Lipids 855775P: 1,2,dipalmitoyl-sn-glycero-3-phosphoethanolamine 
(DPPE) > 99 % from Sigma P1348; RNA from baker’s yeast from Sigma R6750; 
Poly(Lys:Phe, 1:1) hydrobromide from Sigma P3250; Poly(Lys:Tyr, 1:9) hydrobromide form 
Sigma P2025; polylysine 0.1 % w/v from Sigma P8920; bovine serum albumin from Sigma 
A3294. 
2.2. Preparation of functionalized CNTs.  
The appropriate amount of CNT (0.15 mg to 2 mg) was mixed with 1 mL of cationic 
surfactant (0.3 mg.mL-1 in double distilled water) and the mixture was ultrasonicated in a 
Soniprep for 40 s (4 cycles of 10 s on and 10 s off) and then sonicated for 2 h in water bath (3 
W) at room temperature. The suspension was then centrifuged at 13200 rpm for 10 minutes 
and the supernatant was pippeted off. 500 L of f-CNTs were placed in Microcon centrifugal 
devices, regenerated cellulose filter 100 KDa, and centrifuged at 13200 rpm for 5 minutes, the 
filtered was then washed three times with 50 L of bidistilled water and finally recovered by 
resuspending in 500 L of bidistilled water. 
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2.3. Preparation of surfactant:CNT optimisation curves.  
To obtain these solubilization curves, different amounts of CNTs (0.075 mg, 0.225 mg, 0.3 
mg, 0.45 mg, 0.75 mg, 0.9 mg) were mixed with 400 L of distilled water. Then, 100 L of 
surfactant solution 1.5 mg.mL-1 were added and the samples were sonicated as described 
above.  
2.4. Preparation of f-CNTs-DNA complexes.  
80 L of the f-CNTs prepared as described above at different concentrations were mixed with 
2 L of plasmid DNA of 340 g.mL-1. Complexes were allowed to form for 30 min at room 
temperature.  
2.5. Gel electrophoresis.  
0.8 % agarose gel electrophoresis in tris-acetate-EDTA (TAE) buffer was used to study the 
interaction of plasmid DNA with functionalized carbon nanotubes. The gel was run for 45 
min at 90 V. 40 % sucrose was used as loading buffer for the plasmid DNA-f-CNTs 
complexes (a 10 L sample were charged in each well prepared by mixing 8 L of the 
complexes with 2 l of loading buffer l) and ethidium bromide was used for DNA staining. 
2.6. Molecular absorption spectroscopy.  
Molecular absorption spectra were recorded in a Varian Cary 5000 UV-VIS-NIR 
spectrophotometer using a 1 cm optical pathway quartz cuvette.  
3. Results and discussion  
3.1. Functionalization of SWCNTs, DWCNTs and MWCNTs with cationic surfactants  
SWCNTs, DWCNTs and MWCNTs were used for this study and several surfactants were 
tested (see figure 1): benzalkonium chloride, polyethyleneimine (PEI), 1-pyrenemethylamide 
hydrochloride (PMA), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethylene glycol)2000 (PL-PEG-NH2), 1-stearoyl-2-hydroxy-sn-glycero-3-
phosphocholine (Lyso-PC), 1,2,dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 
Poly(Lys:Phe, 1:1) hydrobromide and Poly(Lys:Tyr, 1:9) hydrobromide. The overall 
    
? ? 7? ? ? ? ? ? 7 
objective was to functionalize CNTs for the development of methods to attach DNA to CNTs. 
Therefore, we selected surfactants carrying cationic groups such as amine and choline in order 
to bind negatively charged plasmid DNA.  
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Figure 1. Surfactant structures: 1) benzalkonium chloride, 2) pyrenemethylamine (PMA), 3) 
polyethylenimine (PEI), 4) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethylene glycosl)2000] (PL-PEG-NH2), 5) 1-stearoyl-2-hydroxy-sn-glycero-3-
phosphocholine (Lyso PC), 6) 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 7) 
Poly(Lys:Phe, 1:1), 8) Poly(Lys:Tyr, 1:9). 
 
Our method of dispersion of CNTs was to mix the CNTs with surfactants to promote 
suspension by sonication, and centrifugation in order to remove the bundles complexes. These 
dispersion method produce individual nanotubes which was confirmed by atomic force 
microscopy measurements (see supplementary material, figures S1a-c). Besides, the 
efficiency of solubilisation was measured by VIS-NIR spectroscopy as CNTs absorb in this 
optical region. A 730 nm absorption line was selected as the working wavelength to estimate 
the quantity of solubilized CNTs. This working wavelength was selected as suspended carbon 
nanotubes absorb at this wavelength which is also free of background absorption from the 
tested surfactants (see supplementary material, figures S2-S5). In figure 2, a set of spectra as a 
function of dispersed CNT concentration keeping constant the surfactant concentration is 
shown. As can be seen, as the concentration of dispersed CNTs increases the absorption at 
730 nm linearly increases. Furthermore, the presence of the surfactant, do not contribute to the 
absorbance value at this wavelength (the linear calibration curve crosses at zero value at the y 
axis). This result shows that any free surfactant or non-covalently attached to CNTs do not 
interfere in the measurement of the dispersed CNT concentration which shows that this 
method can be used to determine the dispersion yield.   
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Figure 2. Set of spectra at increasing concentrations of dispersed MWCNT-PEI. PEI 
concentration was kept constant at 0.3 mgmL-1 and different volumes of functionalized 
MWCNTs were added. In the insert the absorption value at 730 nm as a function of the 
concentration of dispersed MWCNT-PEI is presented showing a linear relationship. 
 
We found that the ratio of surfactant to CNT was crucial in order to optimise the 
dispersion[20]. An example of one of these dispersion curves is shown in figure 3, showing 
MWCNTs dispersed with Lyso PC. In this dispersion curves the concentration of surfactant 
was kept constant and the amount of CNTs was varied in the dispersion mixture. The yield of 
dispersion of CNTs was obtained by measuring the absorption value of the suspension at the 
selected wavelength, as it was stated above. As can be seen, as the amount of CNTs in the 
dispersion mixture increases the concentration of dispersed CNTs increases until a maximum 
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is reached where the optimum conditions for dispersion are obtained. Above this optimal 
concentration of nanotubes in the dispersion mixture, the yield of dispersed nanotubes 
decreases. This is likely to be due to limiting concentrations of surfactant being shared 
between large numbers of nanotubes such that insufficient active surfactant is available for 
solubilising each nanotube. This effect support the fact that the CNTs are actually being 
dispersed by the surfactant as limiting concentrations of surfactant lead to not properly or not 
completely dispersed CNTs. 
0
1
2
3
4
5
6
0 0.5 1 1.5 2
MWCNT initial concentration, mgmL-1
A
bs
or
ba
nc
e 
73
0 
nm
 
Figure 3. These optimisation curves were performed with all the surfactants tested and here 
as an example the solubilization curve for MWCNTs with LysoPC at a concentration of 0.3 
mg.mL-1 is shown. Data obtained from triplicates at each MWCNT initial concentration. A 
proper dilution was made to obtain an absorbance value in the linear range of the 
spectrophotometer. 
 
It was clear that with each of the surfactants tested, there was an optimum ratio of surfactant 
to CNTs for maximum solubilisation as can be seen in table 1. It was generally observed that 
the optimal mass of CNTs solubilised with low molecular weight surfactants tended to be 
higher than the optimum mass obtained with higher molecular weight surfactants, attributed to 
the increased hydrophobicity of the low molecular weight compounds.  
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SURFACTANT SWCNTs DWCNTs MWCNTs 
BENZALKONIUM 5 1.5 5 
PMA 6 5 6 
PEI 5 3 6 
PL-PEG-NH2 2 0.5 3 
LYSO PC 0.5 0.5 2 
DPPE 0.5 5 2 
POLY(Lys:Phe, 1:1) 3 6 1.5 
POLY(Lys:Tyr, 1:9) 2 6 2 
 
Table 1. Optimum CNT/surfactant ratio for the best dispersion. In this table the optimum 
CNT/surfactant (w/w) for each surfactant are given.  
 
Figure 4 compares this efficiency when solubilisation has been optimised for each surfactant. 
It can be observed that the efficiency of solubilisation of three types of nanotubes was in the 
following type order of nanotubes MWCNTs > SWCNTs > DWCNTs for benzalconium, PEI, 
PL-PEG-NH2 and poly(Lys:Tyr, 1:9), MWCNTs>DWCNTs>SWCNTs for Lyso PC, 
SWCNTs>MWCNTs>DWCNTs for PMA and DPPE, and DWCNTs>SWCNTs>MWCNTs 
for poly(Lys:Phe, 1:1). When comparing surfactants, the best conditions for solubilization of 
CNTs were obtained with phospholipids, followed by non-biological surfactants and finally 
polypeptides. When comparing the solubilization yield for the non-biological surfactants, PEI 
solubilised better than low molecular weight surfactants (benzalconium and PMA). When the 
excess surfactant was removed in the case of benzalkonium and PMA, the CNTs become not 
dispersed, indicating that solubilisation with these surfactants requires free surfactant in 
equilibrium with the f-CNTs. PL-PEG-NH2 is significantly more efficient than DPPE, which 
differs primarily in the absence of a PEG group, suggesting that the PEG part of PL-PEG-NH2 
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molecule plays an important role in the solubilization process. Conversely, the high 
solubilization yield for Lyso PC compared well to DPPE suggesting that increasing the 
number of acyl chains (in DPPE) decreases the solubilisation efficiency.  
 
 
 
 
 
 
 
 
 
 
Figure 4. Solubilization (expressed as the absorbance at 730 nm of the suspension) as a 
function of the surfactant used for the different kinds of CNTs: SWCNTs, DWCNTs and 
MWCNTs, in the optimal conditions found for solubilisation (these optimal conditions refer 
to the optimum found when getting the solubilisation curve as shown in figure 3). 
 
 
3.2. Optimization of DNA binding 
To test the use of dispersed CNTs with the cationic surfactants as gene carriers, we studied the 
binding of plasmid DNA to these dispersed CNTs by agarose gel electrophoresis. The plasmid 
used for this study was the pGL3 plasmid (from Promega) that encodes the luciferase enzyme 
(lane 2 figure 5A). Binding of plasmid DNA to functionalized CNTs inhibits EtBr 
intercalation[21], as the DNA is in a condensed form. The level of binding can thereby be 
assessed by the measurement of the non bound DNA. The CNTs dispersed by the non 
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covalent attachment of cationic surfactants described above complexed with DNA 
(CNT:DNA) were prepared for each surfactant at various mixing ratios to determine the 
effectiveness of DNA binding. In this way, a constant amount of plasmid DNA was incubated 
with decreasing concentrations of dispersed CNTs. After running the agarose gel, the excess 
of plasmid DNA can be followed as a band for free plasmid DNA (figure 5A lanes 5-8). The 
dispersed CNTs that most effectively bound the DNA were the PL-PEG-NH2, poly(Lys:Phe, 
1:1), and PEI, whereas the other kind of dispersed CNTs did not show any DNA binding (see 
supplementary material, figure S6). A constant amount of plasmid DNA was also incubated 
with decreasing amounts of free surfactants as a control (see supplementary material, table 
S1). It was observed that only PL-PEG-NH2, poly(Lys:Phe, 1:1), and PEI surfactants were 
able to bind plasmid DNA. It was also found that the surfactant non-covalently attached to 
CNTs is more efficient to bind plasmid DNA. After determining the amount to surfactant 
attached to CNTs (see supplementary material), it was found that surfactant bound to CNTs 
leads to a better condensation of DNA. This conclusion makes the non-covalent attachment of 
cationinc surfactants to CNTs a good method for the condensation and binding of DNA onto 
CNTs.  
 
 
 
 
 
 
 
Figure 5. Agarose gel electrophoresis for the f-SWCNTs that effectively bind plasmid DNA: 
A) PEI, B) PL-PEG-NH2 and C) poly(Lys:Phe, 1:1). Lane 1: ladder, lane 2: pGL3 plasmid 
alone 6.8 ng.L-1, lanes 3-8: f-SWCNT:plasmid DNA complexes with plasmid 6.8 ng.L-1 
1 2 3 4 5 6 7 8
A
1 2 3 4 5 6 7 8
B
1 2 3 4 5 6 7 8
C
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and different dilutions of f-SWCNTs from 1/1 to 1/105 (1/1 refers to the best conditions found 
for solubilization of SWCNTs: 51 g.mL-1 for PEI, 56 g.mL-1 for PL-PEG-NH2 and 37 
g.mL-1 for poly(Lys:Phe, 1:1). 
 
The DNA binding capacity of each form of dispersed CNTs can be estimated from Figure 5 
by reference to the lowest concentration of nanotubes that demonstrates detectable DNA 
binding (for instance, lane 5 in Figure 5A). By normalising this value to the DNA 
concentration it is possible to obtain a DNA binding capacity of each f-CNT as shown in 
Table 2. It can be seen that the best results were obtained for PEI which has 10 times more 
binding yield compared to poly(Lys:Phe, 1:1) and 100 times more than PL-PEG-NH2. The 
other f-CNTs showed negligible DNA binding.  
 
SURFACTANT RELATIVE 
SOLUBILIZATION 
YIELD FOR SWCNTs 
RELATIVE 
SOLUBILIZATION 
YIELD FOR DWCNTs 
RELATIVE 
SOLUBILIZATION 
YIELD FOR MWCNTs 
WEIGHT OF BOUND DNA 
PER WEIGHT OF f-
SWCNTs (mg DNA.mg-1 f-
SWCNTs) 
BENZALKONIUM 0.98 0.22 0.55 - 
PMA 0.47 0.18 0.20 - 
PEI 0.91 0.25 1.00 120 
PL-PEG-NH2 0.10 0.46 1.00 0.092 
LYSO PC 1.00 0.36 1.00 - 
DPPE 0.13 0.03 0.02 - 
POLY(Lys:Phe, 1:1) 0.67 1.00 0.26 18.2 
POLY(Lys:Tyr, 1:9) 0.19 0.14 0.12 - 
 
Table 2. Properties of the f-CNTs. The relative solubilization yield were normalized to those 
obtained which the highest solubilization yield (PL-PEG-NH2 for SWCNTs and LysoPC for 
DWCNTs and MWCNTs).  
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3.3. Functionalization of RNA-wrapped SWCNTs by a bilayer approach  
We also examined functionalization of SWCNTs with biological molecules such as nucleic 
acids and proteins. RNA-wrapped CNTs are an attractive method of solubilising CNTs 
because the RNA gives high solubilisation yields and is non-cytotoxic[22]. However, RNA-
wrapping confers negative charges on the carbon nanotubes which then makes them 
unsuitable for DNA binding. To overcome this problem we investigated the use of a cationic 
ion or molecule that can act as bridge between the negatively charged RNA wrapping the 
CNT, and the negatively charged plasmid DNA (Figure 6). The following cationic polymers 
were investigated: poly(Lys:Phe, 1:1), PEI and polylysine (data not shown). The best results 
were obtained using the cationic polymer polylysine as a bridging molecule. With 
poly(Lys:Phe, 1:1) and PEI it was observed a higher aggregation of the dispersed CNTs 
owing to the cationic molecules acting as ionic bridges between negatively charged RNA-
wrapped CNTs. As this aggregation was lower for polylysine the studies with this 
functionalization method were carried out with this polymer. Furthermore, it was quantified 
the amount of plasmid DNA that polylysine on its own is able to bind as a control. This 
amount was determined as 1.40 mg DNA per mg of polylysine which is higher than for PEI 
and poly(Lys:Phe, 1:1) (see supplementary material, table S1). This property also makes 
polylysine a good choice for the development of this bilayer approach for DNA binding to 
carbon nanotubes. 
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Figure 6.  Bilayer approach with RNA-wrapped CNTs for plasmid DNA binding. 
 
The effect of concentration of cationic polymer on DNA solubilisation was investigated by 
agarose gel electrophoresis (Figure 7). The results showed that the complex between RNA-
wrapped CNTs and polylysine is positively charged when the concentration of polylysine is 
high which is the best condition for DNA binding (see figure 7A) we observe. As the 
concentration of polylysine is decreased, the binary complex becomes negatively charged 
because the RNA is in excess of the polylysine. There is also a RNA:polylysine ratio at which 
the binary complex becomes neutral. These effects on functionalized CNT surface charge can 
be observed during the electrophoresis process of the sample preparation (see supplementary 
material, figure S7), negatively charged CNTs run towards the positive electrode and vice 
versa (although this can be seen only in the well as the CNTs are too long and rigid to enter 
the agarose). In Figure 7B the plasmid DNA concentration is optimised. These studies show 
that the optimum DNA binding is 0.071 mg DNA per mg RNA-wrapped CNTs, when 
working with 45 μg polylysine per mg of RNA-wrapped CNTs. This data confirms that the 
condensation of plasmid DNA is more efficient in this bilayer approach than with polylysine 
on its own. 
-
- -
-
-
- - -
-
-
- -
-
-
- - -
-
- -
Mg2+ ---- -
- - -
Mg2+
Mg2+ ---- -
- - -
Mg2+
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+ +
+
-
- -
- --
--
-
- -
- --
--
PLASMID DNA
RNA-WRAPPED CNTs
CATIONIC POLYMER
    
? ? 17? ? ? ? ? ? 17 
 
 
 
 
 
Figure 7. Agarose gel electrophoresis for f-SWCNTs with the bilayer approach with RNA-
wrapped CNTs. A) effect of polylysine concentration in plasmid DNA binding: lane 1: ladder, 
lane 2: pGL3 plasmid 1.8 ngL-1, lanes 3-8 RNA-wrapped CNTs (34 g.mL-1) with different 
concentrations of polylysine from 1.5 mg.mL-1 to 0.015 μg.mL-1. B) lane 1: ladder, lane 2: 
pGL3 plasmid 1.8 ng.L-1, lanes 3-8: RNA-wrapped CNTs-polylysine complexes at different 
dilutions from 1/1 to 1/105 starting in the same conditions as lane 5 in gel A. 
 
4. Conclusions  
In conclusion, we have compared the solubilization properties of SWCNTs, DWCNTs and 
MWCNTs with different kinds of surfactants using non-covalent functionalization. The best 
conditions for solubilization are with the use of phospholipids with PL-PEG-NH2 for 
SWCNTs and LysoPC for DWCNTs and MWCNTs. Furthermore, the solubilization yields 
with the surfactants tested are in general higher for MWCNTs and SWCNTs than for 
DWCNTs. The solutions of f-CNTs obtained by the solubilization methods presented here are 
very stable (several months). The use of these functionalized CNTs for development of gene 
delivery systems was also studied. The best conditions for plasmid DNA binding were 
obtained with PEI, but, given its cytotoxicity, the best combination for solubilization and 
DNA binding is poly(Lys:Phe, 1:1), which is less toxic. Furthermore, a bilayer 
functionalization method based on RNA-wrapped CNTs and the use of cationic polymers 
shows that comparable solubilisation and DNA binding can be achieved by this method. 
1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8
A B
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Overall, this study is important as good optimisation strategies for CNT functionalisation for 
gene delivery are crucial if CNT are to be used in a healthcare scenario. 
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